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Well-defined amphiphilic block copolymers composed of hydrophilic and hydrophobic
blocks linked through an acid-labile acetal bond were synthesized directly by RAFT poly-
merization using a new poly(ethylene glycol) (PEG) macroRAFT agent modified with an
acid-labile group at its R-terminal. The new macroRAFT agent was used for polymeriza-
tion of poly(t-butyl methacrylate) (PtBMA) or poly(cholesterol-methacrylate) (PCMA) to
synthesize well-defined block copolymers with a PEG block sheddable under acidic con-
ditions. The chain extension polymerization kinetics showed known traits of RAFT poly-
merization. The molecular weight distributions of the copolymers prepared using the
new macroRAFT agent remained below 1.2 during the polymerizations and the molecular
weight of the copolymers was linearly proportional to monomer conversions. The acid-
catalyzed hydrolysis behavior of the PEG-macroRAFT agent and the PEG-b-PtBMA
(Mn = 13,600 by GPC, PDI = 1.10) was studied by GPC, 1H NMR and UV–vis spectroscopy.
The half-life of acid-hydrolysis was 70 min at pH 2.2 and 92 h at pH 4.0. The potential use
of the pH-labile shedding behavior of the copolymers was demonstrated by conjugating a
thiol-modified siRNA to x-pyridyldisulfide modified PEG-b-PCMA. The resultant PEG-b-
PCMA-b-siRNA triblock modular polymer released PCMA-b-siRNA segment in acidic
and siRNA segment in reductive conditions, as confirmed by polyacrylamide gel
electrophoresis.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
pH-responsive soluble carriers have been extensively
investigated for drug and gene delivery because of the pH
gradients that exist in both normal and pathological condi-
tions [1–22]. For example, some tumors [23] and inflamma-
tory tissues [24] have are more acidic than the blood and
normal tissue. In addition, although the endocytic pathway
of cells begins near the physiological pH of 7.4, it drops to a
lower pH of 5.5–6.0 in endosomes and approaches to pH
4.5–5.0 in lysosomes [25]. Based on this physiologicaltrigger, the acid-labile polymers are potentially applicable
for constructing drug/gene delivery systems that are trig-
gered to function at acidic sites.
Recently, virus-mimetic polymeric carriers responding
to the pH gradients at intracellular sites have been devel-
oped for intracellular drug delivery [4,15,26–28]. Hoffman,
Stayton et al. were first to report ‘‘bioinspired encrypted
polymers’’ [15]. These polymers synthesized by free radical
copolymerization of hydrophobic monomers and subse-
quent PEG grafting, had an acid-labile PEG mask on the
hydropbobic polymer backbone and were efficient in deliv-
ering peptides and antisense oligonucleotides into the
cytoplasm of cells upon dePEGylation of the hydrophobic
backbone [15]. In recent years, a number of pH-labile dy-
namic carriers adopting similar ‘‘dePEGylation’’ strategies
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ready polymers, for intracellular delivery of genes and siR-
NA [7,8,29–35]. More recently, Lin et al. reported the
in situ synthesis of a block copolymer that employed the
pH-dependent dePEGylation strategy, by atom transfer rad-
ical polymerization [36]. This block copolymer consisted of
poly(ethylene glycol) and poly(2-(dimethylamino)ethyl
methacrylate) segments connected through an acid-labile
cyclic ortho ester linkage was prepared directly from an
ortho ester group-modified PEG-based ATRP initiator syn-
thesized in five-steps.
Considering the value of pH-dependent dePEGylation
strategy for drug delivery applications, we have developed
a reversible-addition fragmentation chain transfer (RAFT)
polymerization-based method for in situ synthesis of
well-defined pH-labile sheddable block copolymers to im-
prove the applicability of the dePEGylation strategy in drug
delivery. The RAFT technique is a powerful tool for synthe-
sis of controlled architectures of a wide-variety of poly-
mers with defined end- and pendant-functionalities,
controlled molecular weights and narrow polydispersities
using mild conditions (such as aqueous solutions and room
temperatures) [37–41].
Herein, a new PEG-macroRAFT agent having an R-group
containing acid-labile acetal bond was first synthesized.
The pH-dependent hydrolysis of the PEG-macroRAFT agent
was characterized by NMR. The block copolymers of PEG
with methylmethacrylate, t-butylmethacrylate (tBMA) or
cholesterol methacrylate (CMA) were synthesized via
chain-extension copolymerization using the new PEG-
macroRAFT agent. The potential use of the pH-labile mac-
roRAFT agent strategy in drug/gene delivery was demon-
strated by preparing reversible micelles of amphiphilic
PEG-b-PtBMA diblock copolymers as potential drug carrier
systems [42–45] and also modular PEG-b-PCMA-b-siRNA
triblock copolymers as potential gene delivery systems
[46,47]. The micelles formed from pH-labile PEG-b-
P(tBMA) copolymers were dePEGylated in response to
acidic environment, as determined by UV–vis spectros-
copy. The modular triblock copolymers of siRNA released
PCMA-b-siRNA and siRNA segments under acidic and
reductive conditions, respectively, as determined by gel
electrophoresis.2. Experimental section
2.1. Materials
The initiator, 2,2-azobisisobutyronitrile (AIBN), was
recrystallized twice from methanol prior to use. Poly(eth-
ylene glycol) methyl ether (PEG5000, number-average
molecular weight Mn 5000 g/mol), 4-formylbenzoic acid,
1,1,1-tris(hydroxymethyl)ethane (tHME), 3 ÅA
0
molecular
sieve and p-toluenesulfonic acid monohydrate (PTSA) were
purchased from Sigma–Aldrich (Australia) and dried in the
vacuum oven prior to use. Methyl methacrylate (MMA)
(Aldrich, 99%), tert-butyl methacrylate (tBMA) (Aldrich,
98%), poly(ethylene glycol) methyl ether acrylate (PEG-A)
(Aldrich, Mn 480 g/mol) were purified via basic alumina
gel column chromatography before use. N,N0-Dicyclohexyl-carbodiimide (DCC), 4-(dimethylamino)pyridine (DMAP),
triethyl amine (TEA) and methacryloyl chloride were pur-
chased from Sigma–Aldrich and used without further puri-
fication. Tetrahydrofuran (THF) was dried by refluxing
with sodium metal. Acetonitrile, diethyl ether, and dichlo-
romethane (Univar, analytical grade reagent) were used as
received. 4-(Cyanopentanoic acid)-4-dithiobenzoate
(CPADB) was synthesized according to the procedure de-
scribed in the literature [37]. Cholesterol was purchased
from Sigma–Aldrich. Cholesterol methacrylate monomer
(CMA) was synthesized according to the procedure de-
scribed elsewhere [48,49]. 50-Sense strand thiol-modified
siRNA (Sense strand: 50ThioMC6 D GCU GAC CCU GAA
GUU CAU CUU 30; Antisense strand: 50 GAU GAA CUU
CAG GGU CAG CUU 30) was purchased from IDT DNA.
2.1.1. Synthesis of PEG formyl benzoic acid ester (1)
PEG5000 (5 g, 1 mmol) and 4-formylbenzoic acid
(0.75 g, 5 mmol) were dissolved in a mixture of dichloro-
methane/THF (30 mL/30 mL), and the resulting solution
was stirred in an ice bath. DCC (206 mg, 1 mmol) and
DMAP (12 mg, 0.1 mmol) were then added to the reaction
solution. The solution was kept stirred overnight. Sedimen-
tation was removed by filtration, and the solvent was re-
moved under reduced pressure. The mixture was purified
by precipitating in cold diethyl ether three times. After
drying in vacuum oven, a white solid was obtained
(3.82 g, yield 72.7%). 1H NMR (300 MHz, CDCl3, d ppm):
10.05 (1H, s, –CHO), 8.12–7.95 (4H, m, phenyl group), 4.5
(2H, t, –CH2CH2OOC), 3.8 (H, m, –OCH2CH2O), 3.2 (3H, s,
–OCH3). The spectrum was shown in Fig. S1 (Supporting
Information).
2.1.2. Synthesis of PEG formyl benzoic acid ester 1,1,1-
tris(hydroxymethyl)ethane acetal (2)
All the glasswares and chemicals were dried prior to
use. A mixture of 1 (0.522 g, 0.1 mmol), 3 ÅA
0
molecular sieve
(1 g), 1,1,1-tris(hydroxymethyl)ethane (tHME) (120 mg,
1 mmol), anhydrous PTSA (6.9 mg, 0.038 mmol), and anhy-
drous THF (10 mL) were heated to reflux for 8 h, and cooled
to ambient temperature. TEA was then added to quench
the reaction. The solvent was removed under reduced
pressure, and crude product was precipitated in cold ether
twice to give white powder (2), yield 80%. 1H NMR
(300 MHz, CDCl3, d ppm): 8.12–7.6 (4H, m, phenyl group),
5.42 (1H, s, -phenyl CHO(O)), 4.5 (2H, t, -CH2CH2OOC), 3.8
(H, m, -OCH2CH2O), 3.2 (3H, s, -OCH3). The spectrum is
shown in Fig. S2 (Supporting Information).
2.1.3. Synthesis of acid labile PEG-macroRAFT agent (3)
Compound 2 (523 mg, 0.1 mmol) was dissolved in
30 mL of dichloromethane, and the solution was stirred
in an ice bath. DCC (103 mg, 0.5 mmol), DMAP (12 mg,
0.1 mmol) and CPADB (140 mg, 0.5 mmol) were then
added, and the solution was kept stirred overnight. Sedi-
mentation was removed by filtering, and the solvent was
removed under reduced pressure. The crude product was
purified by precipitation in cold diethyl ether three times.
After drying in a vacuum oven, a pink solid was obtained
(yield 52.7%). 1H NMR (300 MHz, CDCl3, d ppm):
8.12–7.25 (9H, m, phenyl group), 5.42 (1H, s, -phenyl
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(H, m, -OCH2CH2O), 3.2 (3H, s, -OCH3), 2.7–2.35 (4H, m,
OCCH2CH2C(CH3)CN), 1.98 (3H, s, CH3CCN).
2.1.4. RAFT polymerizations
A number of polymerizations with methyl methacrylate
(MMA), tert-butyl methacrylate (tBMA), poly(ethylene gly-
col acrylate) (PEG-A) and cholesterol methacrylate (CMA)
were performed using the acid labile PEG-macroRAFT
agent 3. The monomer concentration and the ratio of the
monomer, RAFT, and initiator concentrations were varied
as tabulated in Table 1. A typical procedure is given below
for polymerization of t-butyl methacrylate: 55.0 mg
(0.01 mmol) of the RAFT agent 3, 284 mg (2 mmol) of
tert-butyl methacrylate, 0.33 mg (0.002 mmol) of AIBN
were dissolved in 2.1 mL of acetonitrile. Following the seal-
ing of the vial with rubber septum, the polymerization
solution was purged with nitrogen for 30 min in an ice
bath. The solution was placed in an oil bath at 65 C. Ali-
quots (0.1 mL) were taken at predetermined time intervals
and quenched via rapid cooling and exposure to oxygen.
For each sample, the number-average molecular weight
(Mn) and polydispersity index (PDI) were determined by
GPC without purification. The conversions were deter-
mined from the 1H NMR spectra by comparison of the inte-
grations of the vinyl proton peaks of the monomer and the
methyl protons in the polymer. The polymer was concen-
trated by partial evaporation of acetonitrile, and dialyzed
against acetone for 2 days to remove unreacted monomer
and the RAFT agent. After removing the solvent and drying
in vacuum oven for 24 h, the samples were further ana-
lyzed by GPC and 1H NMR.
2.1.5. Synthesis of x-pyridyl-disulfide functional polymer by
aminolysis in the presence of 2,20-dithiodipyridine
50 mg of PEG-b-Poly(cholesterol methacrylate) (PEG-b-
PCMA) (7.76  106 mol, Mn = 6442 g/mol by NMR,
7230 g/mol and PDI = 1.12 by GPC) and 33 mg of 2,20-dithi-
odipyridine (DTP) (1.51  104 mol) were dissolved in ace-
tonitrile (2 mL). The solution was purged for 30 min with
nitrogen to remove the oxygen. Hexylamine (5 lL,
3.77  105 mol) was then added under nitrogen. The solu-
tion was shaken for 5 h, and the color was observed toTable 1
Polymerization of various monomers mediated by PEG-macroRAFT agent 3 under
temperature were 1 M and 65 C, respectively.
Entry Monomer [M]/[RAFT]/[I]a Time (h)
1 MMA 200/1/0.2 10
2 tBMA 200/1/0.2 10
3 tBMA 200/1/0.2 24
4 CMA 30/1/0.2 15
5 CMA 17/1/0.2 15
6 PEG-A 50/1/0.2 8
a [M], [RAFT] and [I] are the feed concentration of monomer, PEG-macroRAFT
b Conversion is monomer conversion that was determined from the 1H NMR s
monomer and methyl protons in the polymer.
c Theoretical molecular weight was calculated by Mn = (conversion (%)  [M]
d GPC molecular weights were determined by GPC (mobile phases, THF).
e PDI is polydispersity index.change from pink to yellow. The polymer was dialyzed
(MWCO = 3500 Da) against an acetone/water mixture
(50/50 V%) for 2 days to remove the excess of DTP, and dia-
lyzed against water for 1 day to remove acetone. The final
polymer was freeze-dried and analyzed by 1H NMR.
2.1.6. Conjugation of siRNA to x-pyridyl-disulfide functional
(PEG-b-PCMA)
50-Sense strand thiol-modified siRNA (2 lL, 0.5 mM in
RNAse free water) was mixed with DTT (5 lL, 200 mM)
solution and kept for 3 h at room temperature. To remove
unreacted DTT, siRNA was precipitated using a large quan-
tity of ethanol. The siRNA pellet was completely resus-
pended in 30 lL of x-pyridyl-disulfide-(PEG-b-PCMA)
solution (50 mg/mL, in 100 mM sodium bicarbonate buffer
at pH 8.5) and left at room temperature for 20 h before
assessing the conjugation by polyacrylamide gel electro-
phoresis (PAGE).
2.2. Instrumental analyses
2.2.1. Nuclear magnetic resonance (NMR) spectroscopy
1H NMR and 13C NMR analyses were performed using a
Bruker 300-MHz spectrometer. Deuterated solvents
(CDCl3, D2O) were purchased from Sigma–Aldrich. Sample
preparation was performed by dissolving 10 mg (for 1H
NMR) and 100 mg (for 13C NMR) of sample in 600 lL of
deuterated solvent.
The hydrolysis kinetic analyses were performed at pH
2.2, 3.0 and 4.0 buffer solutions prepared in D2O. Citrate–
phosphate buffer solution (200 mM, pH 3.0 and 4.0) and
acetic acid buffer solution pH 2.2 were first prepared, and
600 lL of each buffer was freeze-dried. The dried salts
were dissolved in 600 lL of D2O to obtain buffer solutions
in D2O. After mixing the polymer precursor 2 in the NMR
tube, the 1H MNR detection was performed immediately.
The proton signals were collected at every 15 min
(ns = 16 times).
2.2.2. Gel permeation chromatography (GPC)
GPC analyses were performed using tetrahydrofuran
(THF)/0.05 mol% lithium bromide (LiBr) or N,N-dimethyl-
acetamide (DMAC)/0.05 mol% LiBr as the mobile phase.different conditions. In all polymerizations the monomer concentration and
Convb (%) Mn (g/mol) PDIe
Theroc GPCd
40 13,496 14,500 1.12
30 14,016 13,600 1.10
75 26,796 28,400 1.25
18 7953 9100 1.12
15 6656 7200 1.12
35 13,800 14,000 1.20
agent, and initiator AIBN, respectively.
pectra by comparison of the integrations of the vinyl proton peaks of the
/[RAFT] MW(monomer)) + MWRAFT.
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10ATVP Shimadzu solvent delivery system, a SIL-10ADVP
Shimadzu autoinjector, a column set that consisted of a
Phenomonex 5.0 lm bead size guard column and four
5.0 lm Phenomonex Phenogel columns (500, 103, 104,
and 106 Å for the GPC using THF as mobile phase, and
500, 103, 104, and 105 Å for the GPC using DMAC as mobile
phase), and a differential refractive-index detector. Tem-
perature was kept constant at 40 C inside a CTO-10AC
VP Shimadzu column oven. The columns were calibrated
with commercial linear polystyrene standards ranging
from 500 to 106 g/mol.
2.2.3. Dynamic light scattering (DLS)
The hydrodynamic size of micelles was determined
using a Malvern Zetasizer NaNo ZS Instrument (Malvern,
USA) equipped with a 4 mV He–Ne laser operating at
k = 633 nm, an avalanche photodiode detector with high
quantum efficiency, and an ALV/LSE-5003 multiple tau dig-
ital correlator electronics system. Samples were filtered
prior to measurement and measured by scanning five
times of 1.5 min duration without employing the dust filter
function. The samples were prepared at 5 mg/mL
concentration.
To make the polymer micelles for DLS measurements,
PEG-b-PtBMA (Mn = 13,600 by GPC, PDI = 1.10) (10 mg)
was dissolved in 400 lL of acetone, and dialyzed against
water for three days. Milli-Q water was added to make
the final solution volume to be 2 mL.
2.2.4. UV–vis spectrophotometry
A double beam spectrophotometer (HITACHI U-2800)
with a detection range from 190 to 800 nm and a photo-
metric range of five absorbance units was used. Transmit-
tance of PEG-b-PtBMA (Mn = 13,600 by GPC, PDI = 1.10) in
various pH buffer solutions (5 mg/mL) was monitored at
650 nm.
2.2.5. Gel electrophoresis
Gel electrophoresis of PEG-b-PCMA-b-siRNA conjugate
was performed using 15% TBE precast polyacrylamide gels
(Bio-Rad). Samples (containing 0.025 nmol siRNA) were
loaded with 5X TBE urea loading buffer, and run at a con-
stant voltage of 200 V for 30 min using 1X TBE buffer
(tris–borate EDTA, pH 8.0). The gel was stained with 1X
gel red in 100 mM NaCl solution for 30 min. To demon-
strate the release of PCMA-b-siRNA and siRNA segments
from the modular conjugate under acidic and reductive
conditions, the conjugate samples were incubated with
2 lL of acetic acid buffer solution (pH 2.2) or 2 lL of
10 mM DTT for 4 h respectively, and then analyzed by gel
electrophoresis.3. Results and discussion
3.1. Synthesis of acid-labile PEG-macroRAFT agent 3
A new macromolecular RAFT agent with an acid-labile
groupwas synthesizedas shown inScheme1. Thecyclic ace-
tal was chosen as an acid-labile group in the macroRAFTagent. Because acetals can easily be formed using a variety
of hydroxyl groups including primary, secondary, tertiary,
and syn-1,2- and -1,3-diols, and more importantly the rate
of acid-catalyzed hydrolysis can be tailored diversely by
varying the structure of the acetal [50–54].
First, precursor 1 was synthesized by an esterification
reaction between PEG and formyl benzoic acid in the pres-
ence of DCC and DMAP. The integration ratio of phenyl
group (7.92, 8.25 ppm), methylene group adjacent to ester
(4.5 ppm), and methylene group in PEG (3.62–3.85 ppm,
450H) of 2:2:2:450 (Fig. S1 in the Supporting Information),
well-matched with the targeted structure, confirmed the
successful synthesis of pure precursor 1. The following
acetal reaction that was performed with tHEM under anhy-
drous conditions yielded precursor 2 bearing an acid-labile
bond. From the 1H NMR (Fig. S2 in the Supporting Informa-
tion), the appearance of the acetal signal at 5.5 ppm and
the complete disappearance of the benzaldehyde signal
at 10.2 ppm, indicated that the precursor 2 was obtained
successfully. Precursor 2, could then be reacted readily
with CPADB by an esterification reaction without any deg-
radation of the thiocarbonylthio moiety and acetal group
using a carefully optimized molar ratio of DCC and CPADB,
0.95:1. In 1H NMR spectrum (Fig. 1A), the benzaldehyde
signal at 10.05 ppm could not been observed indicating
that no hydrolysis of acetal group took place. Analysis by
13C NMR also confirmed the successful synthesis of the
expected PEG-macroRAFT agent structure (Fig. 1B). How-
ever, from the integration ratio of the phenyl group in
CPADB and phenyl group adjacent to PEG chain, there
was still a trace amount of unreacted precursor 2 left,
although three times precipitation in cold diethyl ether
was performed. Considering that the presence of the pre-
cursor 2 had no effect on the RAFT polymerization, and it
could be easily removed by dialysis after polymerization
(vide infra), no further purification was performed for the
PEG-macroRAFT agent 3.
3.2. Synthesis of block copolymers via RAFT polymerization
The new PEG-macroRAFT agent 3, containing an acid-
labile acetal group, was employed to mediate the chain-
extension copolymerizations. Various monomers (methyl
methacrylate (MMA), tert-butyl methacrylate (tBMA),
poly(ethylene glycol) methyl ether acrylate (PEG-A) and
cholesterol methacrylate (CMA), were employed to test
the new RAFT agent utility in controlling the polymeriza-
tions. A number of polymerizations were performed vary-
ing the ratio of the monomer, RAFT agent, and initiator
concentration as summarized in Table 1. The direct propor-
tionality of [monomer]/[RAFT agent] ratio with the Mn of
the polymers and the low PDI values indicated that the
polymerizations were controlled by PEG-macroRAFT agent
3. The GPC analyses traces of the MMA, CMA, and PEG-A
copolymerizations before purification are shown in
Fig. S3 in Supporting Information.
To further assess the control ability of the PEG-macro-
RAFT agent, a kinetic study was undertaken for polymeri-
zation of t-BMA. An initial [tBMA]/[RAFT]/[AIBN] ratio of
300:1:0.2 was used. The GPC chromatograms (Fig. 2A) of
the polymerization mixtures showed clear shifts with
Scheme 1. Synthesis of the acid-labile PEG-macroRAFT agent and block copolymers (A), and the conjugation of siRNA (B).
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synthesis of the block copolymers. The low molecular
weight trace observed consistently in each GPC trace was
due to the existence of the unreacted precursor 2 in the ini-
tial PEG-macroRAFT agent. This was completely removedafter purification by dialyzing against basic water contain-
ing 0.01% (V%) TEA (Fig. S4 in the Supporting Information).
In addition, linearity of the pseudo-first order kinetic plot
(Fig. 2B) was indicative of a constant radical concentration.
The molecular weight and PDI versus conversion plot
Fig. 1. 1H NMR (A) and 13C NMR (B) (300 MHz, CDCl3) spectra of purified PEG-macroRAFT agent 3.
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arly with conversion. As the reaction proceeded, the
molecular weight distributions remained narrow
(PDI 6 1.20). Overall the polymerization results demon-
strated that the new RAFT agent was able to control the
chain extension polymerization.
3.3. Determination of the polymer hydrolysis
The acid-labile dePEGylation behavior of PEG-b-PtBMA
(Mn = 13,600 by GPC, PDI = 1.10) was investigated first by
GPC. The GPC traces before and after hydrolysis are shown
in Fig. 3. Chromatogram A shows the PEG-b-PtBMA before
hydrolysis, and chromatogram B shows the same polymer
after incubating in acetic acid solution (pH 2.2) for 24 h at37 C. While the Mn of the polymer before hydrolysis was
13600 g/mol, two traces (Mn 7700 and 6100 g/mol) were
obtained after incubation in acidic solution. The Mn of
the traces after hydrolysis was in good agreement with
the Mn of the copolymer before the hydrolysis. The reten-
tion time of the modified PEG (precursor 2) is the same
with that of the longer elution time trace in chromatogram
b, which indicated that the hydrolysis of the copolymer
took place at the acetal position, and the two traces in
the chromatogram could be ascribed to PtBMA and the
modified PEG (precursor 2).
The pH-dependent hydrolysis behavior of the copoly-
mer was further confirmed by UV–vis spectroscopy. Since
the block copolymers synthesized with tBMA, MMA and
CMA have an amphiphilic character, they should be able
Fig. 2. RAFT polymerization of tert-butyl methacrylate (tBMA) using PEG-macroRAFT agent 3 in acetonitrile at 65 C. [tBMA]0/[RAFT]0/[AIBN]0 = 300/1/0.2,
[tBMA]0 = 1.0 mol/L; (A) GPC traces; (B) kinetics plot; (C) evolution of the number average molecular weight (Mn) and polydispersity index (PDI) versus
conversion. The experimental molecular weight was measured by GPC calibrated with polystyrene standards using an RI detector.
Fig. 3. GPC traces of PEG-b-PtBMA before (a) and after (b) hydrolysis, and
the precursor 2 (c).
Fig. 4. UV–vis spectrometric measurements of PEG-b-PtBMA solution, at
pH 2.2 (j), pH 3.0 (d) and pH 4.0 (N).
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tions. Amphiphilic block copolymer micelles are useful
tools for various drug delivery strategies. They are usually
designed to be triggered to disassemble into their unimers
or undergo complete degradation after delivering their
therapeutic cargo. Micelles to be formed from acid-cleav-
able modular amphiphilic block copolymers would enable
the disassembly of the structures at acidic environments.
PEG-b-PtBMA (Mn = 13,600 by GPC, PDI = 1.10) in water
(5 mg/mL) formed micelles as confirmed by DLS (data notshown). The hydrodynamic diameter of the micelles in
water was approximately 30 nm (PDI = 0.143). The micelle
solutions at different pHs were investigated by measuring
the transmittance of the solutions using a UV–vis
spectrometer (Fig. 4). The obvious decrease of the trans-
mittance at pH 2 with time, was attributed to the
2902 X. Huang et al. / European Polymer Journal 49 (2013) 2895–2905disappearance of micelles due to the hydrolysis of the ace-
tal bond in the copolymer, leading to dePEGylation of the
copolymers and subsequent separation of water-insoluble
PtBMA block from aqueous solution.
After initial verification of the hydrolysis behavior of
the modular block copolymers by GPC and UV–vis spec-
trometry, a more detailed study of the hydrolysis rate
was undertaken by 1H NMR. The precursor 2 which has
better water solubility than the block copolymers was used
in these experiments. 1H NMR signals of precursor 2 in
acidic solutions were recorded at predetermined time
intervals in various pH D2O solutions at 37 C. As seen in
Fig. 5A, with increasing reaction times, the hydrolysis can
be clearly monitored by the appearance of the aldehyde
proton signal at 10.05 ppm with increasing intensity. Also,
the signals of phenyl group after hydrolysis could be ob-
served at 7.9 and 8.2 ppm. The hydrolysis percentage was
calculated based on the integration ratio between the phe-
nyl group at 7.6 ppm and total phenyl group peaks at 7.5–
8.3 ppm. By plotting hydrolysis percentage versus time
(Fig. 5B), the half-life of the acetal group in the polymer
were deduced about 70 min at pH 2.2 and 92 h at pH 4.0.
3.4. Modular PEG-b-PCMA-b-siRNA conjugates
To further demonstrate the potential use of acid-revers-
ible modular copolymer structure, a thiol-modified siRNA
was conjugated to PEG-b-PCMA block copolymer synthe-Fig. 5. The hydrolysis kinetics of acetal group in precursor 2, determined at pH 2
pH 3.0 and 4.0, see Fig. S5 in the Supporting Information) and (B) the hydrolysisized using the new macroRAFT agent. A low molecular
weight copolymer PEG-b-PCMA (Mn = 6442 by 1H NMR,
Mn = 7200 by GPC, PDI 1.12) was used in these experi-
ments to minimize the steric hindrance effects during the
end-group conjugation of the copolymer with siRNA.
The 1H NMR spectrum of the polymer PEG-b-PCMA is
given in Fig. 6A. The proton signals of the phenyl group
adjacent to PEG (d = 8.05 and 7.55 ppm), the phenyl group
adjacent to thiocarbonylthio (d = 7.8, 7.5 and 7.35 ppm),
and vinyl group in cholesterol (d = 5.35 ppm) are all clearly
observed. Moreover, the integration ratio of the proton sig-
nal of the phenyl group adjacent to PEG (d = 8.05 ppm) and
the acetal group (d = 5.5 ppm) of 2:1, and the absence of
benzaldehyde signal observed at 10.5 ppm indicated that
the acetal group was maintained during the
polymerization.
The thiocarbonylthio end group of the polymers synthe-
sized by RAFT polymerization can be easily functionalized
with pyridyl disulfide group by aminolysis using an amine
compound and 2,20-dithiodipyridine (DTP) together to
yield stable pyridyl disulfide (PDS)-functionalized poly-
mers [38–40,55,56]. Following this strategy, x-pyridyl
disulfide-functional PEG-b-PCMA was obtained by amino-
lyzing the copolymer in the presence of hexylamine and
DTP. 1H NMR spectrum of the purified polymer (Fig. 6B)
confirmed the presence of the pyridyl disulfide group on
the polymer chains, as evidenced by the existence of new
signals at 8.4, 7.65 and 7.02 ppm which were ascribed to.2, 3.0 and 4.0, at 37 C. (A) 1H NMR spectrum at pH 2.2, (for the spectra at
s percentages at various pHs based on the 1H NMR results.
Fig. 6. 1H NMR spectrum (CDCl3) (A) of purified PEG-b-PCMA (Mn determined by 1H NMR, 6442 g/mol; Mn determined by GPC, 7200 g/mol; and PDI, 1.12),
and (B) after functionalizing the x-end group of the polymer with a pyridyl disulfide group.
X. Huang et al. / European Polymer Journal 49 (2013) 2895–2905 2903the pyridyl protons. Subsequently, a 30-antisense-thiol
modified siRNA [57,58] was conjugated to x-pyridyl disul-
fide-functional PEG-b-PCMA. The final modular conjugate,
PEG-b-PCMA-b-siRNA contained an acid-cleavable acetal
bond between the PEG and PCMA segments and a reduc-
ible disulfide bond between the PCMA and siRNA
segments. The modular conjugate was expected to releasePCMA-b-siRNA segment under acidic conditions and siRNA
under reductive conditions. Here it should be noted that
under acidic conditions the release of siRNA together with
a cellular membrane-destabilizing block such as PCMA
[48] would be desirable for trafficking siRNA to
cytosol from endocytic compartments such as endosomes
or lysosomes. Subsequent to the release of the
Fig. 7. Polyacrylamide gel electrophoresis of the siRNA–PEG-b-PCMA
conjugates. Lanes 1 and 2: PEG-b-PCMA-b-siRNA after incubation in
acidic and reducing conditions respectively, lane 3 PEG-b-PCMA-b-siRNA;
lane 4: free siRNA.
2904 X. Huang et al. / European Polymer Journal 49 (2013) 2895–2905membrane-destabilizing block-siRNA conjugate, siRNA is
expected to be released from the membrane destabilizing
block in the reducing environment of cytosol. The slow
hydrolysis kinetic of the copolymers prepared by the new
macroRAFT agent 3, presented in this study, clearly does
not offer the desired release profile for cytoplasmic
delivery siRNA. However, following the RAFT polymeriza-
tion-based strategy reported in this study, it is possible
to generate a variety of macroRAFT agents containing ace-
tal or ketal bonds with faster hydrolysis kinetics suitable
for endocytic pathway as the hydrolysis kinetics of acetals
and ketals can be well-controlled by the substituent
groups [50,51].
The acid and thiol labile reversibility of PEG-b-PCMA-b-
siRNA was investigated using polyacrylamide gel electro-
phoresis (PAGE) (Fig. 7). After conjugation of siRNA with
the diblock copolymer, an obvious shift to higher molecu-
lar weight (lane 3) was observed compared with the free
siRNA (lane 4). The release of PCMA-b-siRNA and siRNA
in acidic and reductive conditions, respectively, was con-
firmed by the disappearance of the higher molecular
weight band in the gel. It should be noted that after acid-
catalyzed hydrolysis, the PEG chain (Mn = 5000 g/mol)
was removed from the conjugate, leaving the PCMA (Mn
1440 g/mol) conjugated siRNA, PCMA-b-siRNA (Mn
18,925 g/mol),which has a molecular weight very close to
the free siRNA (17,485 g/mol), as observed in lane 1.4. Conclusions
A new strategy which is based on the use of an acid-
hydrolyzable PEG macroRAFT agent to prepare block
copolymers and their bioconjugates has been outlined. This
new strategy provides a versatile, RAFT polymerization-based route to pH-labile dynamic drug/gene carriers adopt-
ing ‘‘dePEGylation’’ strategy.Acknowledgments
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